IL164077A0 - Sustained release formulation of tramadol - Google Patents

Sustained release formulation of tramadol

Info

Publication number: IL164077A0
Authority: IL; Israel
Prior art keywords: tramadol; sustained release; release formulation; formulation; sustained
Prior art date: 2002-03-22

Application number

IL16407703A

Other languages

English (en)

Original Assignee

Cilag Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-22

Filing date

2003-03-21

Publication date

2005-12-18

2003-03-21 Application filed by Cilag Ag filed Critical Cilag Ag

2005-12-18 Publication of IL164077A0 publication Critical patent/IL164077A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL16407703A 2002-03-22 2003-03-21 Sustained release formulation of tramadol IL164077A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP02076130		2002-03-22
PCT/EP2003/003050 WO2003080031A1 (en)	2002-03-22	2003-03-21	Sustained release formulation of tramadol

Publications (1)

Publication Number	Publication Date
IL164077A0 true IL164077A0 (en)	2005-12-18

Family

ID=28051804

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16407703A IL164077A0 (en)	2002-03-22	2003-03-21	Sustained release formulation of tramadol

Country Status (13)

Country	Link
US (1)	US20060018962A1 (xx)
EP (1)	EP1490036A1 (xx)
JP (1)	JP2005537221A (xx)
KR (1)	KR20050009983A (xx)
CN (1)	CN1642532A (xx)
AU (1)	AU2003215671A1 (xx)
CA (1)	CA2479252A1 (xx)
IL (1)	IL164077A0 (xx)
MX (1)	MXPA04009256A (xx)
PL (1)	PL374350A1 (xx)
RU (1)	RU2336864C2 (xx)
WO (1)	WO2003080031A1 (xx)
ZA (1)	ZA200407411B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060172006A1 (en) *	2003-10-10	2006-08-03	Vincent Lenaerts	Sustained-release tramadol formulations with 24-hour clinical efficacy
US8168228B2 (en) *	2003-10-17	2012-05-01	Sandoz Ag	Antibiotic clarithromycin micropellet compositions
JP4965261B2 (ja) *	2004-10-01	2012-07-04	日本臓器製薬株式会社	固形医薬製剤
WO2007008752A2 (en)	2005-07-07	2007-01-18	Farnam Companies, Inc.	Sustained release pharmaceutical compositions for highly water soluble drugs
EA014739B1 (ru)	2005-09-09	2011-02-28	Лабофарм Инк.	Композиция тразодона для введения один раз в день
ES2744495T3 (es) *	2006-03-30	2020-02-25	Nippon Zoki Pharmaceutical Co	Preparación farmacéutica sólida
US9259426B2 (en) *	2006-07-20	2016-02-16	Gilead Sciences, Inc.	4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
CN101095666B (zh) *	2007-08-14	2010-10-06	石药集团欧意药业有限公司	一种盐酸曲马多缓释片剂及其制备方法
CN101467984B (zh) *	2007-12-25	2012-05-23	上海医药工业研究院	一种曲马多鼻用凝胶剂及其制备方法和用途
US20100003322A1 (en) *	2008-07-03	2010-01-07	Lai Felix S	Enteric coated hydrophobic matrix formulation
CN101780039A (zh) *	2010-03-05	2010-07-21	南京海陵中药制药工艺技术研究有限公司	曲马多多囊泡脂质体及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3652589A (en) *	1967-07-27	1972-03-28	Gruenenthal Chemie	1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
GB8601204D0 (en) *	1986-01-18	1986-02-19	Boots Co Plc	Therapeutic agents
US5292534A (en) *	1992-03-25	1994-03-08	Valentine Enterprises, Inc.	Sustained release composition and method utilizing xanthan gum and an active ingredient
IL109460A (en) *	1993-05-10	1998-03-10	Euro Celtique Sa	Controlled release formulation comprising tramadol
DE4329794C2 (de) *	1993-09-03	1997-09-18	Gruenenthal Gmbh	Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
US5399358A (en) *	1993-11-12	1995-03-21	Edward Mendell Co., Inc.	Sustained release formulations for 24 hour release of metroprolol
JPH08295637A (ja) *	1995-04-27	1996-11-12	Green Cross Corp:The	口腔部局所投与剤
AU729529B2 (en) *	1997-06-06	2001-02-01	Depomed, Inc.	Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
WO1999001111A1 (en) *	1997-07-02	1999-01-14	Euro-Celtique, S.A.	Stabilized sustained release tramadol formulations
US6607748B1 (en) *	2000-06-29	2003-08-19	Vincent Lenaerts	Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
EP1322303A1 (en) *	2000-10-03	2003-07-02	Penwest Pharmaceuticals Co.	Delivery system for multi-pharmaceutical active materials at various release rates
US20020106408A1 (en) *	2000-12-01	2002-08-08	Johnatan Bacon	Prolamin-based sustained-release compositions and delayed-onset compositions
EP1385486A4 (en) *	2001-04-18	2006-05-17	Nostrum Pharmaceuticals Inc	NEW COATING OF SLOW RELEASE PHARMACEUTICAL COMPOSITION

2003
- 2003-03-21 JP JP2003577861A patent/JP2005537221A/ja not_active Withdrawn
- 2003-03-21 EP EP03744847A patent/EP1490036A1/en not_active Withdrawn
- 2003-03-21 CA CA002479252A patent/CA2479252A1/en not_active Abandoned
- 2003-03-21 PL PL03374350A patent/PL374350A1/xx not_active Application Discontinuation
- 2003-03-21 AU AU2003215671A patent/AU2003215671A1/en not_active Abandoned
- 2003-03-21 RU RU2004131213/15A patent/RU2336864C2/ru not_active IP Right Cessation
- 2003-03-21 US US10/508,615 patent/US20060018962A1/en not_active Abandoned
- 2003-03-21 MX MXPA04009256A patent/MXPA04009256A/es unknown
- 2003-03-21 CN CNA038065762A patent/CN1642532A/zh active Pending
- 2003-03-21 IL IL16407703A patent/IL164077A0/xx unknown
- 2003-03-21 WO PCT/EP2003/003050 patent/WO2003080031A1/en active Application Filing
- 2003-03-21 KR KR10-2004-7014814A patent/KR20050009983A/ko not_active Application Discontinuation
2004
- 2004-09-15 ZA ZA200407411A patent/ZA200407411B/en unknown

Also Published As

Publication number	Publication date
MXPA04009256A (es)	2005-01-25
AU2003215671A1 (en)	2003-10-08
CN1642532A (zh)	2005-07-20
EP1490036A1 (en)	2004-12-29
KR20050009983A (ko)	2005-01-26
US20060018962A1 (en)	2006-01-26
ZA200407411B (en)	2005-08-31
JP2005537221A (ja)	2005-12-08
PL374350A1 (en)	2005-10-17
RU2336864C2 (ru)	2008-10-27
CA2479252A1 (en)	2003-10-02
RU2004131213A (ru)	2005-08-10
WO2003080031A1 (en)	2003-10-02

Publication	Publication Date	Title
EP1549296A4 (en)	2006-08-09	METFORMIN FORMULATIONS WITH DELAYED RELEASE
EP3395340B8 (en)	2019-12-11	Rapid dissolution formulation of cinacalcet hcl
IL236190A0 (en)	2015-01-29	Controlled release of anti-infections
IL159048A0 (en)	2004-05-12	Sustained release formulation
EP1684689A4 (en)	2007-11-28	VENLAFAXINE PREPARATION WITH PROLONGED RELEASE
EP1537880A4 (en)	2009-07-01	PREPARATION FOR PROLONGED RELEASE
IL165349A0 (en)	2006-01-15	Microcapsule formulations
IL166424A0 (en)	2006-01-15	Sustained release formulations comprising lamotigine
EG24479A (en)	2009-08-03	Modified release pharmaceutical formulation
AU2002337967A1 (en)	2005-01-04	Extended release composition containing tramadol
GB0207438D0 (en)	2002-05-08	Formulation
AU2003226748A8 (en)	2003-10-13	Compositions of venlafaxine base
AU2003226487A8 (en)	2003-09-22	Formulation
PL373908A1 (en)	2005-09-19	Immediate release pharmaceutical formulation
IL164077A0 (en)	2005-12-18	Sustained release formulation of tramadol
AU2003219117A1 (en)	2003-10-13	Extended release venlafaxine formulations
AU2003295846A8 (en)	2004-06-18	Pharmaceutical formulations of celcoxib
GB0217078D0 (en)	2002-08-28	Formulation
GB0215591D0 (en)	2002-08-14	Formulation
GB0215589D0 (en)	2002-08-14	Formulation
GB0225040D0 (en)	2002-12-04	Formulation
IL159780A0 (en)	2009-02-11	Extended release venlafaxine tablet formulation
GB0211444D0 (en)	2002-06-26	Controlled release formulations